Purpose: This study explores if patients or their caregivers can safely give a chemotherapy shot at home instead of going to the hospital. This can save time and make it easier for patients.
Key Points:
- Duration: The study length and number of visits will depend on each patient's treatment plan.
- Eligibility: You must be 18 or older, have symptomatic myeloma (a type of blood cancer), and have had at least 4 bortezomib injections at a hospital.
- Requirements: You or a caregiver should be willing and able to give the injection at home after proper training.
What to Consider: You should not join if you have a history of allergies or severe reactions to bortezomib or are currently part of another bortezomib study. Also, if you live far from healthcare or have less than 6 months to live, this study may not be suitable for you. Always discuss with your doctor to see if this study is a good fit for your needs. 😊
How understandable was the trial content above?
Hard to understand
Easy to understand